Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma

Current Medical Research and Opinion

Volumn 22, Issue 3, 2006, Pages 463-470

  Stempel, David A ^a   Riedel, Aylin Altan ^b   Rosenzweig, Jacqueline R Carranza ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Magnifi   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Childhood asthma; Children; Fluticasone propionate; Inhaled corticosteroids; Montelukast; Salmeterol

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; SALMETEROL;

ADOLESCENT; ASTHMA; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DISEASE CONTROL; DRUG UTILIZATION; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; PRESCRIPTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MANAGED CARE PROGRAMS; NEBULIZERS AND VAPORIZERS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33645219998     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X89711     Document Type: Conference Paper

References (29)

1. Dey AN, Schiller JS, Tai DA. Summary health statistics for US children: National Health Interview Survey, 2002 [National Center for Health Statistics]. Vital Health Stat 2004;10
2. Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 2002;51:1-13
3. Diette GB, Markson L, Skinner EA, et al. Nocturnal asthma in children affects school attendance, school performance, and parents' work attendance. Arch Pediatr Adolesc Med 2000;154:923-8
4. Lozano P, Sullivan SD, Smith DH, et al. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999;104:957-63
5. National Asthma Education and Prevention Program Expert Panel. Report: guidelines for the diagnosis and management of asthma. Update on selected topics 2002. J Allergy Clin Immunol 2002;110:S142-S219
6. Childhood Asthma Management Program (CAMP) Research Group. Long-term effects of budesonide or nedocromil in children with asthma. New Engl J Med 2000;343:1054-63
7. Peden DB, Berger WE, Noonan MJ, et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 1998;102:32-8
8. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol 1996;97:742-48
9. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. J Am Med Assoc 1997;277:887-91
10. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-11
11. Smith MJ, Rascati KL, McWilliams BC. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol 2004;92:40-6
12. Schatz M, Cook EF, Nakahiro R, et al. Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. J Allergy Clin Immunol 2003;111:503-8
13. Blais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmissions to hospital for asthma. Am J Respir Crit Care Med 1998;159:126-32
14. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma [Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group]. New Engl J Med 1997;337: 1405-11
15. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Br Med J 2000;320:1368-73
16. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-7
17. Halterman JS, Aligne A, Auinger P, et al. Inadequate therapy for asthma among children in the United States. Pediatrics 2000;105:272-6
18. Finkelstein JA, Lozano P, Farber HJ, et al. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med 2002;156:562-7
19. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med 2001;155:501-7
20. Goodman DC, Lozano P, Stukel TA, et al. Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics 1999;104:187-94
21. Lozano P, Finkelstein JA, Hecht J, et al. Asthma medication use and disease burden in children in a primary care population. Arch Pediatr Adolesc Med 2003;157:81-8
22. Halterman JS, Yoos L, Kaczorowski JM, et al. Providers underestimate symptom severity among urban children with asthma. Arch Pediatr Adolesc Med 2002;156:141-6
23. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002;109:S554-S559
24. Yeatts K, Shy C, Sotir M, et al. Health consequences for children with undiagnosed asthma-like symptoms. Arch Pediatr Adolesc Med 2003;157:540-4
25. Stempel DA, Kelly HW. Approaching value in asthma management: the need to integrate clinical and economic research with the basic science. J Allergy Clin Immunol 2002;109:s503-s510
26. Bilderback A, Rand C, Krishnan J, et al. Adherence with montelukast or fluticasone and outcomes in a 1-year clinical trial in patients with mild persistent asthma. Proc Am Thorac Soc 2005;2:A925
27. Bender B, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self-report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000;85:416-21
28. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax 2002;57:880-4
29. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of deaths from asthma. New Engl J Med 2000;343:332-6